Powered by

-PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility

Aug 06, 2019 - ENP Newswire
Mergers and Acquisitions

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced it has signed a long-term lease agreement with Bristol-Myers Squibb Company (NYSE: BMY).

Under the lease agreement, PTC will gain access to approximately 185,000 square feet of space, including an existing state-of-the-art biologics production facility and supporting research and operations buildings on the BMS Hopewell, N.J.campus. PTC plans to further develop the biologics facility to support gene therapy production and foster innovat...